chr21-32467843-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_058187.5(EVA1C):āc.629C>Gā(p.Pro210Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000479 in 1,608,114 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P210A) has been classified as Uncertain significance.
Frequency
Consequence
NM_058187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EVA1C | NM_058187.5 | c.629C>G | p.Pro210Arg | missense_variant | 4/8 | ENST00000300255.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EVA1C | ENST00000300255.7 | c.629C>G | p.Pro210Arg | missense_variant | 4/8 | 1 | NM_058187.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 151868Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000107 AC: 26AN: 244100Hom.: 1 AF XY: 0.000121 AC XY: 16AN XY: 132226
GnomAD4 exome AF: 0.0000364 AC: 53AN: 1456128Hom.: 1 Cov.: 32 AF XY: 0.0000483 AC XY: 35AN XY: 724438
GnomAD4 genome AF: 0.000158 AC: 24AN: 151986Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.629C>G (p.P210R) alteration is located in exon 4 (coding exon 4) of the EVA1C gene. This alteration results from a C to G substitution at nucleotide position 629, causing the proline (P) at amino acid position 210 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at